KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹17 Cr | ₹18 Cr | ₹20 Cr | ₹41 Cr | ₹21 Cr |
What is the latest Contingent Liabilities ratio of KOPRAN ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹21 Cr |
How is Contingent Liabilities of KOPRAN Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17 Cr | -5.24 | |
| Mar2024 | ₹18 Cr | -9.05 | |
| Mar2023 | ₹20 Cr | -51.22 | |
| Mar2022 | ₹41 Cr | 93.30 | |
| Mar2021 | ₹21 Cr | - | |
Compare Contingent Liabilities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹800.6 Cr | -2.4% | -3.1% | -41.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,751.0 Cr | 0.2% | 7.1% | -7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,634.0 Cr | 1% | 16.8% | 12.7% | Stock Analytics | |
| CIPLA | ₹124,437.0 Cr | -2.7% | 3.5% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,871.0 Cr | 0.6% | 0.4% | 4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,333.0 Cr | -6.4% | -2.7% | -3.9% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -2.4% |
-3.1% |
-41.5% |
| SENSEX | -0.2% |
5% |
5.4% |
You may also like the below Video Courses